Report updated May 11, 2026

Overview · Full Intel report in progress

INR Coagulation Manager is an established medical app that is a paid app. With a 3.0/5 rating from 2 reviews, it shows polarized user reception.

What is INR Coagulation Manager?

INR Coagulation Manager is a medical tool designed to help patients on anticoagulant therapy track INR levels and manage medication regimens. The app supports various medications like Warfarin and Sintrom, offering features such as dosage planning and medication reminders to assist with treatment adherence.

Current Momentum

v3.0 · 5mo ago

Steady

Last updated 175d ago. 5 versions tracked.

AI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.

Competition

Rivals identification in progress

7-Day Rank Pulse 🇺🇸

Medical
#96
NEW

Rating Pulse 🇺🇸

What makes this app unique?

What Does It Look Like?

How Is The App's Momentum Right Now?

Loading...

What Are The Key Features?

INR TrackingStandard

Allows users to log and review their International Normalized Ratio readings.

Medication ManagementStandard

Provides tools to set daily medication reminders and plan recurring weekly dosages.

Cross-Platform IntegrationStandard

Includes an Apple Watch app for managing tracking and reminders, alongside home screen widgets for quick access.

Interaction TrackingStandard

Enables users to maintain a record of food and medication interactions that may impact therapy.

How much does it cost?

Paid

Who Built It?

Enrico Ferro app icon 1
Enrico Ferro app icon 2
Enrico Ferro app icon 3
Enrico Ferro app icon 4

Enrico Ferro

(2)

Providing specialized utility tools for musicians, medical patients, and professionals. Focused on niche productivity and management solutions.

Portfolio

11

Apps

Free 9Paid 1
Music30%
Productivity20%
Education10%

Who is Enrico Ferro?

The publisher operates as a micro-utility developer, targeting fragmented professional and personal management needs rather than mass-market consumer segments. By building specific tools for choir management, medical tracking, and design workflows, they avoid direct competition with broad-category incumbents. The strategic focus appears to be on solving granular, high-friction tasks for specific user groups, though the portfolio lacks a unified brand identity or cross-app ecosystem.

Who is Enrico Ferro for?

  • Niche professionals
  • Musicians
  • Patients requiring structured tracking or management tools
Steady

Portfolio momentum

Released 3 updates across the portfolio in the last 6 months, maintaining a mix of active and legacy titles.

Last release · 10d agoActive apps · 7Abandoned · 4

Analysis in progress, available soon

What do users think recently?

Analysis in progress, available soon

Analysis in progress, available soon

What is the competitive landscape for INR Coagulation Manager?

How's The Medical Market?

How does it evolve in the Medical market?

ChartRankChange
iOSFree#58NEW
iOSGrossing#73NEW

Strategic analysis coming soon

SWOT, key takeaways & outlook

The outtake for INR Coagulation Manager

Key Takeaways

The app provides a centralized digital record for anticoagulant therapy, though a recent database update resulted in the loss of existing user data.

Where Is It Heading?

Trend analysis

Available very soon

Disclosure

Independent intel to help builders create better apps.

AI-powered analysis with editorial review, built from publicly available sources. See methodology.

Marlvel.ai is not affiliated with, endorsed by, or sponsored by INR Coagulation Manager, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Hope this helps & keep building! · Found an error?

What's new in this report

No changes detected yet.

Cite this report

Marlvel.ai. “INR Coagulation Manager Intelligence Report.” Updated May 11, 2026. https://marlvel.ai/intel-report/medical/com-enricoferro-inr-coagulation-manager

Agent Markdown (.md)·

Data licensed under CC-BY-NC 4.0